These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 29684147)

  • 1. Plasma and CSF pharmacokinetics of meropenem in neonates and young infants: results from the NeoMero studies.
    Germovsek E; Lutsar I; Kipper K; Karlsson MO; Planche T; Chazallon C; Meyer L; Trafojer UMT; Metsvaht T; Fournier I; Sharland M; Heath P; Standing JF;
    J Antimicrob Chemother; 2018 Jul; 73(7):1908-1916. PubMed ID: 29684147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population Pharmacokinetics and Dosing Regimen Optimization of Meropenem in Cerebrospinal Fluid and Plasma in Patients with Meningitis after Neurosurgery.
    Lu C; Zhang Y; Chen M; Zhong P; Chen Y; Yu J; Wu X; Wu J; Zhang J
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6619-6625. PubMed ID: 27572392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conventional Versus Prolonged Infusion of Meropenem in Neonates With Gram-negative Late-onset Sepsis: A Randomized Controlled Trial.
    Shabaan AE; Nour I; Elsayed Eldegla H; Nasef N; Shouman B; Abdel-Hady H
    Pediatr Infect Dis J; 2017 Apr; 36(4):358-363. PubMed ID: 27918382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic/pharmacodynamic analysis of meropenem, by Monte Carlo simulation, in both plasma and cerebrospinal fluid in patients with cerebral hemorrhage after external ventricular drainage
.
    Kong L; Xu H; Wu C; Kong X; Yu M; Shi Q; Wu X
    Int J Clin Pharmacol Ther; 2020 Jan; 58(1):50-56. PubMed ID: 31670654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamics of ceftazidime and meropenem in cerebrospinal fluid: results of population pharmacokinetic modelling and Monte Carlo simulation.
    Lodise TP; Nau R; Kinzig M; Drusano GL; Jones RN; Sörgel F
    J Antimicrob Chemother; 2007 Nov; 60(5):1038-44. PubMed ID: 17785282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meropenem pharmacokinetics, pharmacodynamics, and Monte Carlo simulation in the neonate.
    Bradley JS; Sauberan JB; Ambrose PG; Bhavnani SM; Rasmussen MR; Capparelli EV
    Pediatr Infect Dis J; 2008 Sep; 27(9):794-9. PubMed ID: 18645546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal pharmacokinetic and pharmacodynamic analysis of efficacy of meropenem in paediatric patients with bacterial meningitis.
    Ohata Y; Tomita Y; Sunakawa K; Drusano GL; Tanigawara Y
    Int J Antimicrob Agents; 2019 Sep; 54(3):292-300. PubMed ID: 31279154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathecal penetration of meropenem and vancomycin administered by continuous infusion in patients suffering from ventriculitis-a retrospective analysis.
    Mader MM; Czorlich P; König C; Fuhrmann V; Kluge S; Westphal M; Grensemann J
    Acta Neurochir (Wien); 2018 Nov; 160(11):2099-2105. PubMed ID: 30242495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Meropenem Penetration into Cerebrospinal Fluid in Patients with Meningitis After Neurosurgery.
    Zhang Y; Zhang J; Chen Y; Yu J; Cao G; Wu X; Chen M; Wu J; Zhao X
    World Neurosurg; 2017 Feb; 98():525-531. PubMed ID: 27867128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meropenem vs standard of care for treatment of neonatal late onset sepsis (NeoMero1): A randomised controlled trial.
    Lutsar I; Chazallon C; Trafojer U; de Cabre VM; Auriti C; Bertaina C; Calo Carducci FI; Canpolat FE; Esposito S; Fournier I; Hallik M; Heath PT; Ilmoja ML; Iosifidis E; Kuznetsova J; Meyer L; Metsvaht T; Mitsiakos G; Pana ZD; Mosca F; Pugni L; Roilides E; Rossi P; Sarafidis K; Sanchez L; Sharland M; Usonis V; Warris A; Aboulker JP; Giaquinto C;
    PLoS One; 2020; 15(3):e0229380. PubMed ID: 32130261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Population and Developmental Pharmacokinetic Analysis To Evaluate and Optimize Cefotaxime Dosing Regimen in Neonates and Young Infants.
    Leroux S; Roué JM; Gouyon JB; Biran V; Zheng H; Zhao W; Jacqz-Aigrain E
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6626-6634. PubMed ID: 27572399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short versus long infusion of meropenem in very-low-birth-weight neonates.
    Padari H; Metsvaht T; Kõrgvee LT; Germovsek E; Ilmoja ML; Kipper K; Herodes K; Standing JF; Oselin K; Lutsar I
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4760-4. PubMed ID: 22733063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population Pharmacokinetic Analysis of Meropenem After Intravenous Infusion in Korean Patients With Acute Infections.
    Kim YK; Lee DH; Jeon J; Jang HJ; Kim HK; Jin K; Lim SN; Lee SS; Park BS; Kim YW; Shin JG; Kiem S
    Clin Ther; 2018 Aug; 40(8):1384-1395. PubMed ID: 30093133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics and probability of target attainment of meropenem in critically ill patients.
    Mattioli F; Fucile C; Del Bono V; Marini V; Parisini A; Molin A; Zuccoli ML; Milano G; Danesi R; Marchese A; Polillo M; Viscoli C; Pelosi P; Martelli A; Di Paolo A
    Eur J Clin Pharmacol; 2016 Jul; 72(7):839-48. PubMed ID: 27048201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of meropenem in pancreatic juice and site-specific pharmacodynamic target attainment against Gram-negative bacteria: dosing considerations.
    Kondo N; Ikawa K; Murakami Y; Uemura K; Sudo T; Hashimoto Y; Ohge H; Morikawa N; Sueda T
    Pancreatology; 2014; 14(2):95-9. PubMed ID: 24650961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A multicenter epidemiological study of neonatal bacterial meningitis in parts of South China].
    Collaborative Study Group for Neonatal Bacterial Meningitis
    Zhonghua Er Ke Za Zhi; 2018 Jun; 56(6):421-428. PubMed ID: 29886604
    [No Abstract]   [Full Text] [Related]  

  • 17. Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution.
    Roberts JA; Kirkpatrick CM; Roberts MS; Robertson TA; Dalley AJ; Lipman J
    J Antimicrob Chemother; 2009 Jul; 64(1):142-50. PubMed ID: 19398460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacokinetics and pharmacodynamics of meropenem in the cerebrospinal fluid of neurosurgical patients.
    Tsumura R; Ikawa K; Morikawa N; Ikeda K; Shibukawa M; Iida K; Kurisu K
    J Chemother; 2008 Oct; 20(5):615-21. PubMed ID: 19028626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental Population Pharmacokinetics-Pharmacodynamics of Meropenem in Chinese Neonates and Young Infants: Dosing Recommendations for Late-Onset Sepsis.
    Wu YE; Kou C; Li X; Tang BH; Yao BF; Hao GX; Zheng Y; van den Anker J; You DP; Shen AD; Zhao W
    Children (Basel); 2022 Dec; 9(12):. PubMed ID: 36553441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meropenem Population Pharmacokinetics and Simulations in Plasma, Cerebrospinal Fluid, and Brain Tissue.
    Alshaer MH; Barlow B; Maranchick N; Moser M; Gramss L; Burgmann H; Jalali VA; Wölfl-Duchek M; Jäger W; Poschner S; Plöchl W; Reinprecht A; Rössler K; Gruber A; Zeitlinger M; Peloquin CA; Hosmann A
    Antimicrob Agents Chemother; 2022 Aug; 66(8):e0043822. PubMed ID: 35862739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.